Reports
The following list of reports reflects the latest in findings and outcomes in medical research as presented at major medical meetings and published peer-reviewed medical journals. In this section you can view reports from important congresses as well as summaries of some recently published journal articles. Please let us know if you have a particular area of interest you would like to see covered.
PRIORITY PRESS - 10th Canadian Immunization Conference
Invasive Meningococcal Disease: Focus on the New Serogroup B Disease Vaccine
Vancouver, BC / December 3-5, 2012
Vancouver - Each year in Canada, approximately 200 individuals are affected by invasive meningococcal disease (IMD), and about half of them are children. Mortality from IMD has remained essentially unchanged since the 1950s with a...
PRIORITY PRESS - 63rd McGill Annual Refresher Course for Family Physicians
Update on Family Medicine: Oral Anticoagulants, Stroke Management, Ovarian Cancer
Montréal, Quebec / November 26-28, 2012
Montreal - At this year’s McGill Refresher Course, delegates heard about potentially practice-altering patient management strategies for common conditions. In a plenary session, they were informed about using dabigatran, rivaroxaban...
PRIORITY PRESS - 4th European Multidisciplinary Meeting on Urological Cancers (EMUC 2012)
Targeting the Androgen Receptor in Castrate-resistant Prostate Cancer: A Step Forward
Barcelona, Spain / November 16-18, 2012
Barcelona - In prostate cancer, medical or surgical androgen ablation therapy leads to tumour regression and a rapid decline in prostate-specific antigen (PSA). However, progression of the cancer despite castrate levels of testosterone is a...
PRIORITY PRESS - 76th Annual Meeting of the American College of Rheumatology (ACR)
Protection Against Radiologic Progression in Rheumatoid Arthritis with JAK Inhibition Appears Similar to IV Biologics
Washington, DC / November 10-14, 2012
Washington, DC - Oral agents that target intracellular pathways of inflammation are showing remarkable similarities to injectable monoclonal antibodies in the control of rheumatoid arthritis (RA). Along with phase III data supporting the...
MEDICAL FRONTIERS - 63rd Annual Meeting of the American Association for the Study of Liver Diseases
Direct-acting Antiviral Agents in Chronic HCV Therapy: Exploring Less Complex Regimens
Boston, Massachusetts / November 9-13, 2012
Boston - Therapy for chronic hepatitis C viral infections has changed significantly, thanks to the development of direct-acting antiviral agents that target specific vulnerabilities of the virus in all or most of its variant forms....
PRIORITY PRESS - 64th Annual Meeting of the National Hemophilia Foundation
Hemophilia Management: Evaluating RICE and Factor Replacement Therapy with Longer Half-life
Orlando, Florida / November 8-10, 2012
Orlando - Conservative therapy in the management of joint and muscle bleeding in patients with hemophilia has consisted primarily of interventions known collectively as RICE: rest, ice, compression and elevation. A critical assessment of...
MEDICAL FRONTIERS - 4th World Congress on Controversies to Consensus in Diabetes, Obesity and Hypertension (CODHy)
Novel Insulin-Independent Mechanism of Action Hits Triple Targets in Type 2 Diabetes
Barcelona, Spain / November 8-11, 2012
Barcelona - Management of type 2 diabetes mellitus (T2DM) implies more than achieving good glycemic control as most patients have comorbid conditions including high blood pressure (BP) and dyslipidemia. Most are overweight or obese as well....
PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)
Options for Iron Correction and Erythropoiesis Stimulation: Better Benefit:Risk Through Individualized Therapy
San Diego, California / October 30 - November 4, 2012
San Diego - More sophisticated strategies for the treatment of anemia in patients with chronic kidney disease (CKD), including those on dialysis, are being driven by new options for replenishing iron and stimulating erythropoiesis. The...
PRIORITY PRESS - 2012 Kidney Week of the American Society of Nephrology (ASN)
Halting Threat of Kidney Failure by Hemolytic Uremic Syndrome and Other Thrombotic Microangiopathies
San Diego, California / October 30-November 4, 2012
San Diego - Two-year results with a targeted monoclonal antibody (MAb) against the complement protein C5 demonstrated that the kidney damage caused by atypical hemolytic uremic syndrome (aHUS) and shiga-toxin producing Escherichia coli HUS...